Rocket Pharmaceuticals, Inc.
RCKT- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001281895
In the last 90 days, Rocket Pharmaceuticals, Inc. insiders filed 0 open-market purchases and 7 sales; 180 institutions reported holding it in 13F filings for Q2 2026, worth $340.9M in total; Maverick Capital is the only superinvestor holding it.
Q1 2021 vs. Q4 2020
How the institutions holding Rocket Pharmaceuticals, Inc. changed between Q4 2020 and Q1 2021.
All holders in Q1 2021All holders in Q4 2020
| Measure | Q4 2020 | Q1 2021 | Change |
|---|---|---|---|
| Holders | 0 | 173 | +173 |
| Shares | 0 | 62.0M | +62.0M |
| Value | $0 | $2.75B | +$2.75B |
New holders (173)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q1 2021 but not at the end of Q4 2020.
Showing the largest 100 of 173 by value.
Sold out (0)
Institutions that held Rocket Pharmaceuticals, Inc. at the end of Q4 2020 and filed for Q1 2021 without it.
None.